Jun. 18 at 12:44 PM
This morning I reviewed 500+ stocks across my watchlists and portfolio and ran them through my evaluation criteria:
• Near-term catalyst
• Revenue/fundamental improvement
• Institutional interest
• Cash runway & dilution risk
• Under
$20/share
• Room to run
• Not already extended
After multiple rounds of filtering, these names survived the first pass:
$TGEN $PCT $HUMA $SES $CLVT
Next step is digging deeper into the financials, cash runway, profitability trends, dilution risk, and catalyst paths to see if the story matches the numbers.
Watchlist only for now. Research continues. Thoughts?